Drug Shortage Report for PRIVA-ATORVASTATIN
| Report ID | 108464 |
| Drug Identification Number | 02482894 |
| Brand name | PRIVA-ATORVASTATIN |
| Common or Proper name | Atorvastatin |
| Company Name | PHARMAPAR INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ATORVASTATIN |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 500 |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2020-03-11 |
| Estimated end date | 2020-04-13 |
| Actual end date | 2020-04-14 |
| Shortage status | Resolved |
| Updated date | 2020-04-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1565 BOUL LIONEL-BOULET VARENNES, QUEBEC CANADA J3X 1P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-04-15 | English | Compare |
| v5 | 2020-04-14 | French | Compare |
| v4 | 2020-04-14 | English | Compare |
| v3 | 2020-03-12 | English | Compare |
| v2 | 2020-03-11 | French | Compare |
| v1 | 2020-03-11 | English | Compare |
Showing 1 to 6 of 6